Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Suzhou Zelgen Biopharmaceuticals Co., Ltd.

Share · CNE100003RP1 (XSHG)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Suzhou Zelgen Biopharmaceuticals Co., Ltd.
No Price
Closing Price XSHG 29.04.2026: 100,64 CNY
29.04.2026 05:52
Current Prices from Suzhou Zelgen Biopharmaceuticals Co., Ltd.
ExchangeTickerCurrencyLast TradePriceDaily Change
XSHG: SSE
SSE
688266.SS
CNY
29.04.2026 05:52
100,64 CNY
1,22 CNY
+1,23 %
Share Float & Liquidity
Free Float 83,52 %
Shares Float 221,07 M
Shares Outstanding 264,71 M
Company Profile for Suzhou Zelgen Biopharmaceuticals Co., Ltd. Share
Suzhou Zelgen Biopharmaceuticals Co., Ltd. researches and develops, manufactures, and sells medicines in the People's Republic of China. It offers small molecule and recombinant protein drugs for the treatment of liver cancer, non-small cell lung cancer, colorectal cancer, thyroid cancer, nasopharyngeal carcinomas, myelofibrosis, hemorrhage, and hepatobiliary diseases. The company was founded in 2009 and is based in Kunshan, the People's Republic of China.

Company Data

Name Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Company Suzhou Zelgen Biopharmaceuticals Co., Ltd.
Website https://www.zelgen.com
Primary Exchange XSHG SSE
ISIN CNE100003RP1
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Zelin Sheng
Market Capitalization 26 Mrd.
Country China
Currency CNY
Employees 0,9 T
Address No. 209, Chenfeng Road, 215300 Kunshan
IPO Date 2020-01-23

Ticker Symbols

Name Symbol
SSE 688266.SS
More Shares
Investors who hold Suzhou Zelgen Biopharmaceuticals Co., Ltd. also have the following shares in their portfolio:
AIR PR.+CHEM 25/37
AIR PR.+CHEM 25/37 Bond
Citius Oncology, Inc.  - Common Stock
Citius Oncology, Inc. - Common Stock Share